Abstract
Gammi-danguieumja (GD) is clinically used in South Korea for treating atopic dermatitis. However, its effects in experimental models remain unknown. We investigated a possible effect of GD on cytokines production using human T cell line (MOLT-4) or human mast cell line. As a result, GD (0.01 mg/mL)-containing medium in stimulated culture supernatants increased IL-2 and IFN-γ, and decreased IL-4 secretion in MOLT-4. GD (0.01–1 mg/mL)-containing medium in stimulated culture supernatants dose-dependently and significantly decreased IL-8, IL-13, and tumor necrosis factor-alpha secretion on the phorbol 12-myristate 13-acetate and A23187-stimulated HMC-1. In addition, GD inhibited histamine release from activated mast cells. These results suggest that GD contributes to the regulation of atopic allergic reactions.
Similar content being viewed by others
References
Luo, Z. H. 1993. The use of Chinese traditional medicines to improve impaired immune functions in scald mice. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 9:56–58, 80.
Han, S. B., Y. H. Kim, C. W. Lee, S. M. Park, H. Y. Lee, K. S. Ahn, I. H. Kim, and H. M. Kim. 1998. Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai. Immunopharmacology 40(1):39–48.
Lu, Y., D. Chen, J. Deng, and L. Tian. 2003. Effect of Smilax china on adjunctive arthritis mouse. Zhong Yao Cai. 26(5):344–346.
Li, R. W., L. G. David, S. P. Myers, and D. N. Leach. 2003. Anti-inflammatory activity of Chinese medicinal vine plants. J. Ethnopharmacol. 85(1):61–67.
Cheong, H., E. J. Choi, G. S. Yoo, K. M. Kim, S. Y. Ryu, and C. Ho. 1998. Desacetylmatricarin, an anti-allergic component from Taraxacum platycarpum. Planta Med. 64(6):577–578.
Takii, T., S. Kawashima, T. Chiba, H. Hayashi, M. Hayashi, H. Hiroma, H. Kimura, Y. Inukai, Y. Shibata, A. Nagatsu, J. Sakakibara, Y. Oomoto, K. Hirose, and K. Onozaki. 2003. Multiple mechanisms involved in the inhibition of proinflammatory cytokine production from human monocytes by N-(p-coumaroyl) serotonin and its derivatives. Int Immunopharmacol. 3(2):273–277.
Johansson, S. G., and T. Bieber. 2002. New diagnostic classification of allergic skin disorders. Curr. Opin. Allergy Clin. Immunol. 2:403–406.
Rudikoff, D., and M. Lebwohl. 1997. Atopic dermatitis. Lancet 3 351:1715–1721.
Hopkin, J. M. 1997. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr. Opin. Immunol. 9:788–792.
Leung, D. Y. M. 2000. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. All. Clin. Immunol. 105:860–876.
Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787–793.
Romagnani, S., P. Parronchi, M. M. D’Elios, P. Romagnani, F.Annuziato, M. P. Piccinni, R. Manetti, S. Sampognaro, C.Mavilia, M. De Carli, E. Maggi, and G. F. Del Prete. 1997. An update on human Th-1 and Th-2 cells. Int. Arch. All. Immunol. 113:153–156.
Olsson, N., D. D. Taub, and G. Nilsson. 2004. Regulation of Mast Cell Migration by TH1 and TH2 Cytokines: Identification of Tumour Necrosis Factor-α and Interleukin-4 as Mast Cell Chemotaxins. Scand. J. Immunol. 59(3):267–272.
Mihm, M. C., N. A. Soter, H. F. Dvorak, and K. F. Austen. 1976. The structure of normal skin and the morphology of atopic eczema. J. Invest. Dermatol. 67:305–312.
Rothe, M. J., M. Nowak, and F. A. Kerdel. 1990. The mast cell in health and disease. J. Am. Acad. Dermatol. 23:615–624.
Rukwied, R., G. Lischetzki, F. McGlone, G. Heyer, and M. Schmelz. 2000. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: A dermal microdialysis study. Br. J. Dermatol. Jun. 142(6):1114–1120.
Walsh, L. J., G. Trinchieri, H. A. Waldorf, D. W. Whitaker, and G. F. Murphy. 1991. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 88(10):4220–4224.
Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. A. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, G. R. Bullock, M. K. Church, and S. T. Holgate. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381–1386.
Moller, A., U. Lippert, D. Lessmann, G. Kolde, K. Hamann, P. Welker, D. Schadendorf, T. Rosenbach, T. Luger, and B. M. Czarnetzki. 1993. Human mast cells produce IL-8. J. Immunol. 151:3261–3266.
Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills. 1995. Activated mast cells produce interleukin-13. J. Exp. Med. 181:1373–1380.
Ackermann, L., and I. T. Harvima. 1998. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM1 in the epidermis. Arch. Dermatol. Res. 290:353–359.
Kim, H. M., and Y. M. Lee. 1999. Role of TGF-beta1 on the IgE-dependent anaphylaxis reaction. J. Immunol. 162:4960–4965.
Shin, B. K., E. H. Lee, and H. M. Kim. 1997. Suppression of L-histidine decarboxylase mRNA expression by methyleugenol. Biochem. Biophys. Res. Commun. 232:188–191.
Shin, H. Y., J. S. Kim, N. H. An, R. K. Park, and H. M. Kim. 2004. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci. 74(23):2877–2887.
Yurt, R. W., R. W. Leid, and K. F. Austen. 1977. Native heparin from rat peritoneal mast cells. J. Biol. Chem. 252(2):518–521.
Shore, P. A., A. Burkhalter, and V. H. Cohn. 1959. A method for fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182–186.
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55–63.
Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827–4833.
Cooper, K. D. 1994. Atopic dermatitis: Recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102:128–137.
Yoshizawa, Y., H. Nomaguchi, S. Izaki, and K. Kitamura. 2002. Serum cytokine levels in atopic dermatitis. Clin. Exp. Dermatol. 27:225–229.
Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells as a source of multi-functional cytokines. Immunol. Today 11:458–464.
Plaut, M., J. H. Pierce, C. J. Watson, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcɛRI or to calcium ionophores. Nature 339:64– 67.
Shin, H. Y., Y. S. Song, H. M. Kim, and T. Y. Shin. 2004. Inhibitory effect of inflammatory cytokines production from activated mast cells by Gamisopoonghwanghyul-tang. Immunopharmacol Immunotoxicol. 26(4):587–596.
Jaffe, J. S., M. C. Glaum, D. G. Raible, T. J. Post, E. Dimitry, D. Govindarao, Y. Wang, and E. S. Schulman. 1995. Human lung mast cell IL-5 gene and protein expression: Temporal analysis of upregulation following Ig mediated activation. Am. J. Respir. Cell Mol. Biol. 13:665–675.
Kim, S. J., E. J. Lee, Y. S. Song, H. J. Jeong, K. M. Lee, H. R. Kim, H. J. Chae, T. Y. Shin, Y. K. Kim, S. H. Hong, and H. M. Kim. 2005. Cheongyeolsaseuptang inhibits production of TNF-alpha, IL-6 and IL-8 as well as NF-kappa B activation in human mast cells. J. Ethnopharmacol. 97(1):83–88.
Krishnaswamy, G., R. Martin, E. Walker, C. Li, F. Hossler, K. Hall, and D. S. Chi. 2003. Moraxella catarrhalis induces mast cell activation and nuclear factor kappaB-dependent cytokine synthesis. Front. Biosci. 8:A40–A47.
Sumito, S., M. Kawai, Y. Kasajima, and T. Hamamoto. 1992. Increased plasma tumor necrosis factor-alpha concentration in atopic dermatitis. Arch. Dis. Child 67:277–279.
Groves, R. W., M. H. Allen, E. L. Ross, J. N. W. N. Barker, and D. M. Mac Donald. 1995. Tumor necrosis factor alpha is proinflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132:345–352.
Kapp, A., A. Textor, J. Krutmann, and A. Moller. 1990. Immunomodulating cytokines in atopic dermatitis and psoriasis: Production of tumor necrosis factor and lymphotoxin by mononuclear cells in vitro. Br. J. Dermatol. 122:587–592.
Osborn, L., C. Hession, R. Tizard, C. Vassalo, S. Luhowsky, G. Chi Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203–1211.
Pober, J. S., M. A. Gimbrone, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893–1896.
Bittlemann, D., and T. Casale. 1994. Allergic models and cytokines. Am. J. Respir. Crit. Care Med. 150:72–76.
De Vries, J. M., E. G. Langeveld-Wildschut, F. C. van Reijsen, G. R. Dubios, J. A. van den Hoek, I. C. Bihari, D. van Wichen, R. A. de Weger, E. F. Knol, T. Thepen, and C. A. F. M. Bruinjzeel-koomen. 1998. Adhesion molecule expression on skin endothelia in atopic dermatitis: Effects of TNF-α and IL-4. J. Allergy Clin. Immunol. 102:461–468.
Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin 8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97–179.
Neuber, K., K. Steinbrucke, L. Kowalzik, I. Kohler, and J. Ring. 1995. Cytokine-mediated effects of peripheral blood mononuclear cells from patients in a new coculture system. Br. J. Dermatol. 133:750–756.
Euber, K., R. A. Hilger, and W. Konig. 1991. Interleukin-3, interleukin-8, fMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology 73:83–87.
Van Joost, T., M. M. A. Kozel, B. Tank, R. Troost, and E. P. Prens. 1992. Cyclosporin in atopic dermatitis. Modulation in the expression of immunological markers in lesional skin. J. Am. Acad. Dermatol. 27:922–928.
Leung, D. Y. 1998. Molecular basis of allergic diseases. Mol. Genet. Metab. 63:157–167.
Obara, W., Y. Kawa, C. Ra, K. Nishioka, Y. Soma, and M. Mizoguchi. 2002. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 205:11–17.
Borish, L., and B. Z. Joseph. 1992. Inflammation and the allergic response. Med. Clin. North. Am. 76:765–787.
Mousli, M. C., C. Bronner, J. Bockaert, B. Rouot, and Y. Landry. 1990. Interaction of substance P, compound 48/80 and mastoparan with α-subunit C-terminal of G protein. Immunol. Lett. 25:355–358.
Kim, H. M., Y. H. Lee, H. J. Chae, H. R. Kim, S. H. Baek, K. S. Lim, and C. Y. Hwang. 1999. Shini-san inhibits mast cell-dependent immediate-type allergic reactions. Am. J. Chin. Med. 27:377–386.
Tasaka, K., M. Mio, and M. Okamoto. 1986. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann. Allergy 56:464–469.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Na, HJ., Shin, HY., Kim, NH. et al. Regulatory Effects of Cytokine Production in Atopic Allergic Reaction by Gammi-Danguieumja. Inflammation 28, 291–298 (2004). https://doi.org/10.1007/s10753-004-6053-0
Issue Date:
DOI: https://doi.org/10.1007/s10753-004-6053-0